HARMONY: a €40 million project for better care of patients with hematologic malignancies

The Innovative Medicines Initiative (IMI) has approved HARMONY, a project that aims to foster better access and care for patients with various hematologic malignancies (HM) with the use of big data. The project is made up of
51 partners from 11 European countries, including 7 pharmaceutical companies.

More information


Haut de page